BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23664213)

  • 1. Optimization of a novel potent and selective bacterial DNA helicase inhibitor scaffold from a high throughput screening hit.
    Li B; Pai R; Aiello D; Di M; Barnes MH; Peet NP; Bowlin TL; Moir DT
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3481-6. PubMed ID: 23664213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coumarin-based inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicase: chemical optimization, biological evaluation, and antibacterial activities.
    Li B; Pai R; Di M; Aiello D; Barnes MH; Butler MM; Tashjian TF; Peet NP; Bowlin TL; Moir DT
    J Med Chem; 2012 Dec; 55(24):10896-908. PubMed ID: 23231076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicases.
    Aiello D; Barnes MH; Biswas EE; Biswas SB; Gu S; Williams JD; Bowlin TL; Moir DT
    Bioorg Med Chem; 2009 Jul; 17(13):4466-76. PubMed ID: 19477652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triaminotriazine DNA helicase inhibitors with antibacterial activity.
    McKay GA; Reddy R; Arhin F; Belley A; Lehoux D; Moeck G; Sarmiento I; Parr TR; Gros P; Pelletier J; Far AR
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1286-90. PubMed ID: 16343901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus anthracis and Bacillus cereus PcrA helicases can support DNA unwinding and in vitro rolling-circle replication of plasmid pT181 of Staphylococcus aureus.
    Anand SP; Mitra P; Naqvi A; Khan SA
    J Bacteriol; 2004 Apr; 186(7):2195-9. PubMed ID: 15028705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and in vitro inhibition studies of Bacillus anthracis FtsZ: a potential antibacterial target.
    Park HC; Gedi V; Cho JH; Hyun JW; Lee KJ; Kang J; So B; Yoon MY
    Appl Biochem Biotechnol; 2014 Mar; 172(6):3263-70. PubMed ID: 24510482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, molecular docking, binding free energy calculation and molecular dynamics simulation studies of benzothiazol-2-ylcarbamodithioates as
    Jupudi S; Azam MA; Wadhwani A
    J Recept Signal Transduct Res; 2019 Jun; 39(3):283-293. PubMed ID: 31538846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baulamycins A and B, broad-spectrum antibiotics identified as inhibitors of siderophore biosynthesis in Staphylococcus aureus and Bacillus anthracis.
    Tripathi A; Schofield MM; Chlipala GE; Schultz PJ; Yim I; Newmister SA; Nusca TD; Scaglione JB; Hanna PC; Tamayo-Castillo G; Sherman DH
    J Am Chem Soc; 2014 Jan; 136(4):1579-86. PubMed ID: 24401083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic analysis and integrative discovery of active-site subpocket-specific dehydroquinate synthase inhibitors combating antibiotic-resistant Staphylococcus aureus infection.
    Liu Q; Li L; Xu F
    J Bioinform Comput Biol; 2018 Dec; 16(6):1850027. PubMed ID: 30567475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical study of recombinant PcrA from Staphylococcus aureus for the development of screening assays.
    Dubaele S; Martin C; Bohn J; Chène P
    J Biochem Mol Biol; 2007 Jan; 40(1):7-14. PubMed ID: 17244476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel bacterial RNA polymerase inhibitors: pharmacophore-based virtual screening and hit optimization.
    Hinsberger S; Hüsecken K; Groh M; Negri M; Haupenthal J; Hartmann RW
    J Med Chem; 2013 Nov; 56(21):8332-8. PubMed ID: 24112046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyl-sulfamates target the essential glycerol-phosphate acyltransferase (PlsY) in Gram-positive bacteria.
    Cherian PT; Yao J; Leonardi R; Maddox MM; Luna VA; Rock CO; Lee RE
    Bioorg Med Chem; 2012 Aug; 20(16):4985-94. PubMed ID: 22795901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzothioxalone derivatives as novel inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferases (MurA and MurZ).
    Miller K; Dunsmore CJ; Leeds JA; Patching SG; Sachdeva M; Blake KL; Stubbings WJ; Simmons KJ; Henderson PJ; De Los Angeles J; Fishwick CW; Chopra I
    J Antimicrob Chemother; 2010 Dec; 65(12):2566-73. PubMed ID: 20861142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens.
    Jarvest RL; Berge JM; Berry V; Boyd HF; Brown MJ; Elder JS; Forrest AK; Fosberry AP; Gentry DR; Hibbs MJ; Jaworski DD; O'Hanlon PJ; Pope AJ; Rittenhouse S; Sheppard RJ; Slater-Radosti C; Worby A
    J Med Chem; 2002 May; 45(10):1959-62. PubMed ID: 11985462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of potential broad spectrum antimicrobials using C2-symmetric 9-fluorenone alkyl amine.
    Choi SR; Larson MA; Hinrichs SH; Narayanasamy P
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1997-9. PubMed ID: 26965856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, antibacterial evaluation and preliminary structure-activity relationship (SAR) study of benzothiazol- and benzoxazol-2-amine derivatives.
    Ouyang L; Huang Y; Zhao Y; He G; Xie Y; Liu J; He J; Liu B; Wei Y
    Bioorg Med Chem Lett; 2012 May; 22(9):3044-9. PubMed ID: 22494615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of the PcrA helicase of Bacillus anthracis.
    Naqvi A; Tinsley E; Khan SA
    J Bacteriol; 2003 Nov; 185(22):6633-9. PubMed ID: 14594837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.
    Gjorgjieva M; Tomašič T; Barančokova M; Katsamakas S; Ilaš J; Tammela P; Peterlin Mašič L; Kikelj D
    J Med Chem; 2016 Oct; 59(19):8941-8954. PubMed ID: 27541007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high-throughput screen to identify novel small molecule inhibitors of the Werner Syndrome Helicase-Nuclease (WRN).
    Sommers JA; Kulikowicz T; Croteau DL; Dexheimer T; Dorjsuren D; Jadhav A; Maloney DJ; Simeonov A; Bohr VA; Brosh RM
    PLoS One; 2019; 14(1):e0210525. PubMed ID: 30625228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase.
    Jarvest RL; Erskine SG; Forrest AK; Fosberry AP; Hibbs MJ; Jones JJ; O'Hanlon PJ; Sheppard RJ; Worby A
    Bioorg Med Chem Lett; 2005 May; 15(9):2305-9. PubMed ID: 15837314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.